Clinical Trials Directory

Trials / Unknown

UnknownNCT03134625

Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation

Identification of Metabolite Biomarkers Related to Acute Rejection of Patients With Kidney Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The development of acute rejection can only be considered in cases with increasing serum creatinine in patients with kidney transplantation. However, the serum creatinine itself is not specific but also accurate for detection of acute rejection. So The specific biomarker is required for acute rejection of kidney transplant. In this study, the investigators will enroll 200 consecutive kidney transplant patients in Seoul National University Hospital and follow up. Serial collection of urine and serum will be done. Acute rejection specific urine metabolite will be found by LC MS/MS.

Conditions

Timeline

Start date
2016-06-28
Primary completion
2023-07-30
Completion
2023-07-31
First posted
2017-05-01
Last updated
2022-05-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03134625. Inclusion in this directory is not an endorsement.